Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118352392 | 11835239 | 2 | F | 20150831 | 20151218 | 20151215 | 20160101 | EXP | CH-SM-2015-07022 | CH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-083996 | BRISTOL MYERS SQUIBB | 56.60 | YR | M | Y | 0.00000 | 20160101 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118352392 | 11835239 | 1 | PS | LITALIR | HYDROXYUREA | 1 | Oral | 16295 | 500 | MG | CAPSULE | BID | |||||||
| 118352392 | 11835239 | 2 | SS | ATACAND PLUS | CANDESARTAN CILEXETILHYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 12.5 | MG | TABLET | QD | |||||||
| 118352392 | 11835239 | 3 | C | MEPHANOL | ALLOPURINOL | 1 | Unknown | 0 | 300 | MG | QD | ||||||||
| 118352392 | 11835239 | 4 | C | TEMESTA /00273201/ | LORAZEPAM | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 118352392 | 11835239 | 5 | C | JAKAFI | RUXOLITINIB | 1 | Oral | 0 | 20 | MG | BID | ||||||||
| 118352392 | 11835239 | 6 | C | ACIDE FOLIQUE | FOLIC ACID | 1 | Oral | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118352392 | 11835239 | 1 | Leukocytosis |
| 118352392 | 11835239 | 2 | Product used for unknown indication |
| 118352392 | 11835239 | 3 | Product used for unknown indication |
| 118352392 | 11835239 | 4 | Product used for unknown indication |
| 118352392 | 11835239 | 5 | Product used for unknown indication |
| 118352392 | 11835239 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118352392 | 11835239 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118352392 | 11835239 | Gout | |
| 118352392 | 11835239 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118352392 | 11835239 | 2 | 201506 | 20150901 | 0 | |
| 118352392 | 11835239 | 5 | 201501 | 0 |